pifithrin has been researched along with Bladder Cancer in 2 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, L | 1 |
| Mu, D | 1 |
| Mu, H | 1 |
| Tyagi, A | 1 |
| Singh, RP | 1 |
| Agarwal, C | 1 |
| Agarwal, R | 1 |
2 other studies available for pifithrin and Bladder Cancer
| Article | Year |
|---|---|
Sakuranin represses the malignant biological behaviors of human bladder cancer cells by triggering autophagy via activating the p53/mTOR pathway.
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Humans; Matrix Metalloproteinase 2; Plan | 2023 |
Silibinin activates p53-caspase 2 pathway and causes caspase-mediated cleavage of Cip1/p21 in apoptosis induction in bladder transitional-cell papilloma RT4 cells: evidence for a regulatory loop between p53 and caspase 2.
Topics: Apoptosis; Benzothiazoles; Caspase 2; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cytoc | 2006 |